Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scot Garg

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
JACC. Cardiovascular Interventions|June 29, 2020
Effect of Sex Difference of Coronary Microvascular Dysfunction on Long-Term Outcomes in Deferred LesionsJu-Hyun Chung, Kyung Eun Lee, Joo Myung Lee, et al.
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JACC. Cardiovascular Interventions|May 20, 2022
Predicted and Observed Mortality at 10 Years in Patients With Bifurcation Lesions in the SYNTAX TrialKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 31, 2021
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival studyRutao Wang, Kuniaki Takahashi, Scot Garg, et al.
International Journal of Cardiology|September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trialChao Gao, Kuniaki Takahashi, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
International Journal of Cardiology|March 21, 2025
Cumulative plaque burden analysis for phenotyping epicardial coronary artery diseaseTsung-Ying Tsai, Pruthvi C Revaiah, Ali Aldujeli, et al.
Journal of the American College of Cardiology|October 2, 2020
Impact of Peri-Procedural Myocardial Infarction on Outcomes After RevascularizationHironori Hara, Patrick W Serruys, Kuniaki Takahashi, et al.
Atherosclerosis|June 8, 2025
Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: A cross-sectional studyAli Aldujeli, Tsung-Ying Tsai, Ayman Haq, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 24, 2022
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery diseaseMasafumi Ono, Patrick W Serruys, Hideyuki Kawashima, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
JACC. Cardiovascular Interventions|June 29, 2020
Effect of Sex Difference of Coronary Microvascular Dysfunction on Long-Term Outcomes in Deferred LesionsJu-Hyun Chung, Kyung Eun Lee, Joo Myung Lee, et al.
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JACC. Cardiovascular Interventions|May 20, 2022
Predicted and Observed Mortality at 10 Years in Patients With Bifurcation Lesions in the SYNTAX TrialKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 31, 2021
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival studyRutao Wang, Kuniaki Takahashi, Scot Garg, et al.
International Journal of Cardiology|September 17, 2020
Regional variation in patients and outcomes in the GLOBAL LEADERS trialChao Gao, Kuniaki Takahashi, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
International Journal of Cardiology|March 21, 2025
Cumulative plaque burden analysis for phenotyping epicardial coronary artery diseaseTsung-Ying Tsai, Pruthvi C Revaiah, Ali Aldujeli, et al.
Journal of the American College of Cardiology|October 2, 2020
Impact of Peri-Procedural Myocardial Infarction on Outcomes After RevascularizationHironori Hara, Patrick W Serruys, Kuniaki Takahashi, et al.
Atherosclerosis|June 8, 2025
Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: A cross-sectional studyAli Aldujeli, Tsung-Ying Tsai, Ayman Haq, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 24, 2022
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery diseaseMasafumi Ono, Patrick W Serruys, Hideyuki Kawashima, et al.
Pageof 29